IP Library Assignment 044296/0094
Patent Assignment
Reel/Frame 044296/0094

Assignment of Assignor's Interest

Recorded: 2017-12-05 Pages: 7
Assignor
BHI LIMITED PARTNERSHIP
Executed: 2017-03-13
Assignees
THALLION PHARMACEUTICALS INC.
155 WELLINGTON STREET WEST, TORONTO, ONTARIO, M5V 3J7, CANADA
BELLUS HEALTH INC.
275 ARMAND-FRAPPIER BOULEVARD, LAVAL, QUEBEC, H4V 4A7, CANADA
Covered Property (1)
Pharmaceutical Formulations of Amyloid Inhibiting Compounds
Patent: 8,835,500 →
Application: 12/362,971 →
Publication: US 2009/0182056
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 7, 2011
From: BELLUS HEALTH (INTERNATIONAL) LIMITED
To: BELLUS HEALTH INC.
Reel/Frame 026400/0132 →
Assignment of Assignor's Interest Aug 9, 2012
From: BELLUS HEALTH INC.
To: BHI LIMITED PARTNERSHIP
Reel/Frame 028758/0266 →
Assignment of Assignor's Interest Dec 5, 2017
From: THALLION PHARMACEUTICALS INC.
To: BELLUS HEALTH INC.
Reel/Frame 044296/0140 →